CP c.1113T>C ;(p.V371=)

Variant ID: 3-148924050-A-G

NM_000096.3(CP):c.1113T>C;(p.V371=)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Presence of novel compound BCR-ABL mutations in late chronic and advanced phase imatinib sensitive CML patients indicates their possible role in CML progression.

Cancer Biology & Therapy
Akram, Afia Muhammad AM; Iqbal, Zafar Z; Akhtar, Tanveer T; Khalid, Ahmed Mukhtar AM; Sabar, Muhammad Farooq MF; Qazi, Mahmood Hussain MH; Aziz, Zeba Z; Sajid, Nadia N; Aleem, Aamer A; Rasool, Mahmood M; Asif, Muhammad M; Aloraibi, Saleh S; Aljamaan, Khaled K; Iqbal, Mudassar M
Publication Date: 2017-04-03

Variant appearance in text: CP: V371V
PubMed Link: 28278078
Variant Present in the following documents:
  • Main text
View BVdb publication page